REYON PHARMACEUTICAL Co., LTD.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 1964-11-25
- Employees
- 488
- Market Cap
- -
- Website
- http://reyonpharm.co.kr
Safety Study of VM206RY in Subjects With Expression of HER2 in Breast Cancer
Phase 1
Completed
- Conditions
- Breast Cancer
- Interventions
- Biological: VM206DNABiological: VM206Ad
- First Posted Date
- 2013-07-10
- Last Posted Date
- 2015-01-21
- Lead Sponsor
- Reyon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT01895491
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath